SHORT COMMUNICATION - EXPRESSION OF THE P53 TUMOR-SUPPRESSOR GENE IN HUMAN PLACENTA - AN IMMUNOHISTOCHEMICAL STUDY

被引:39
作者
MARZUSCH, K [1 ]
RUCK, P [1 ]
HORNY, HP [1 ]
DIETL, J [1 ]
KAISERLING, E [1 ]
机构
[1] UNIV TUBINGEN,INST PATHOL,D-72076 TUBINGEN,GERMANY
关键词
D O I
10.1016/0143-4004(95)90086-1
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Since human trophoblast undergoes extensive proliferation and exhibits invasive growth comparable to that of a malignant tumour, human placenta at various different stages of gestation was investigated immunohistochemically with the monoclonal antibody Ab-6 for expression of the p53 tumour suppressor gene. p53 protein was detected in the nuclei of a few trophoblastic cells, almost all belonging to the cytotrophoblast and only very few to the syncytiotrophoblast, in nearly all specimens investigated (first trimester 10/10, second trimester 5/5, third trimester 4/5). First trimester trophoblast exhibited increased expression of p53 protein in the juxtastromal areas of cytotrophoblast cell islands and columns, that is, in areas where high proliferative activity and increased expression of the epidermal growth factor receptor have been described in the literature. Staining was also occasionally seen in trophoblast invading the myometrium. It is most likely that immunohistochemically detectable expression of p53 protein in the trophoblast is due not to mutation of the gene, as in malignant tumours, but rather to up-regulation of the p53 tumour suppressor gene, which could be a mechanism for controlling trophoblast proliferation.
引用
收藏
页码:101 / 104
页数:4
相关论文
共 16 条
[1]  
BARTEK J, 1990, ONCOGENE, V5, P893
[2]   THE HUMAN PLACENTA - A MODEL FOR TENASCIN EXPRESSION [J].
CASTELLUCCI, M ;
CLASSENLINKE, I ;
MUHLHAUSER, J ;
KAUFMANN, P ;
ZARDI, L ;
CHIQUETEHRISMANN, R .
HISTOCHEMISTRY, 1991, 95 (05) :449-458
[3]   ADHESIVE AND DEGRADATIVE PROPERTIES OF HUMAN PLACENTAL CYTOTROPHOBLAST CELLS-INVITRO [J].
FISHER, SJ ;
CUI, TY ;
LI, Z ;
HARTMAN, L ;
GRAHL, K ;
ZHANG, GY ;
TARPEY, J ;
DAMSKY, CH .
JOURNAL OF CELL BIOLOGY, 1989, 109 (02) :891-902
[4]   MUTATION IS REQUIRED TO ACTIVATE THE P53 GENE FOR COOPERATION WITH THE RAS ONCOGENE AND TRANSFORMATION [J].
HINDS, P ;
FINLAY, C ;
LEVINE, AJ .
JOURNAL OF VIROLOGY, 1989, 63 (02) :739-746
[5]   USE OF AVIDIN-BIOTIN-PEROXIDASE COMPLEX (ABC) IN IMMUNOPEROXIDASE TECHNIQUES - A COMPARISON BETWEEN ABC AND UNLABELED ANTIBODY (PAP) PROCEDURES [J].
HSU, SM ;
RAINE, L ;
FANGER, H .
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY, 1981, 29 (04) :577-580
[6]   INCREASED EXPRESSION OF MUTANT FORMS OF P53 ONCOGENE IN PRIMARY LUNG-CANCER [J].
IGGO, R ;
GATTER, K ;
BARTEK, J ;
LANE, D ;
HARRIS, AL .
LANCET, 1990, 335 (8691) :675-679
[7]   P53 EXPRESSION IS COMMON IN MALIGNANT MESOTHELIOMA [J].
KAFIRI, G ;
THOMAS, DM ;
SHEPHERD, NA ;
KRAUSZ, T ;
LANE, DP ;
HALL, PA .
HISTOPATHOLOGY, 1992, 21 (04) :331-334
[8]  
Lane D., 1990, ACCOMPLISHMENTS CANC, P252
[9]   P53, C-ERBB-2 AND THE EPIDERMAL GROWTH-FACTOR RECEPTOR IN THE BENIGN AND MALIGNANT PROSTATE [J].
MELLON, K ;
THOMPSON, S ;
CHARLTON, RG ;
MARSH, C ;
ROBINSON, M ;
LANE, DP ;
HARRIS, AL ;
HORNE, CHW ;
NEAL, DE .
JOURNAL OF UROLOGY, 1992, 147 (02) :496-499
[10]   The role of p53 in the normal control of cell proliferation [J].
Milner, Jo .
CURRENT OPINION IN CELL BIOLOGY, 1991, 3 (02) :282-286